Vitamin Supplementation for MTHFR C677T TT Genotype
Direct Recommendation
For individuals with the MTHFR C677T TT genotype, take 5-methyltetrahydrofolate (5-MTHF) 0.4–1 mg daily, methylcobalamin (or hydroxycobalamin) 0.02–1 mg daily, riboflavin 50 mg daily, and vitamin B6 50 mg daily. 1
This combination bypasses your deficient enzyme, reduces homocysteine by 25–37%, and addresses the multiple cofactor dependencies created by your genetic variant. 2, 1
Why 5-MTHF Instead of Regular Folic Acid
Your TT genotype reduces MTHFR enzyme activity by approximately 70%, making standard folic acid ineffective because it requires conversion by the very enzyme you lack. 1
5-MTHF is already in the active form and does not require any enzymatic conversion, making it 25–30% more effective at lowering homocysteine in TT homozygotes. 2, 1
The European Society of Cardiology specifically recommends 5-MTHF for the 677TT genotype because it bypasses the enzymatic defect entirely. 2, 1
The Complete B-Vitamin Protocol
Riboflavin (Vitamin B2): 50 mg daily
Riboflavin is the FAD cofactor that your residual MTHFR enzyme absolutely requires to function—without adequate riboflavin, even your reduced enzyme activity drops further. 1
TT homozygotes show the strongest response to riboflavin supplementation, with a 4.1 µmol/L reduction in homocysteine when riboflavin levels move from lowest to highest quartile. 3
Prioritizing folate without addressing riboflavin is especially harmful for TT genotypes, since riboflavin is the essential cofactor for any residual MTHFR activity. 1
Vitamin B12 (Methylcobalamin or Hydroxycobalamin): 0.02–1 mg daily
Adding B12 provides an additional 7% reduction in homocysteine beyond what 5-MTHF achieves alone. 2, 1
Use methylcobalamin or hydroxycobalamin—never cyanocobalamin—because the active forms are more efficient at lowering homocysteine and don't require conversion. 1
TT homozygotes respond better when both folate and B12 levels are above median, suggesting you need higher doses of both. 1
Vitamin B6 (Pyridoxine): 50 mg daily
B6 supports the transsulfuration pathway, which converts homocysteine to cysteine when the remethylation pathway (dependent on your deficient MTHFR) is impaired. 1
In TT homozygotes, a 2.1 µmol/L reduction in homocysteine occurs when B6 levels move from lowest to highest quartile. 3
Critical Safety Precaution
Never start any folate supplementation without first confirming normal vitamin B12 status or treating B12 deficiency. 1, 4
Folate can mask the hematologic signs of B12 deficiency (correcting anemia) while allowing irreversible neurological damage to progress. 1, 4
Before starting supplements, measure serum B12, methylmalonic acid (MMA), and erythrocyte folate to rule out functional B12 deficiency. 1, 4
Dietary Recommendations
Focus on foods naturally rich in folate—leafy greens, legumes, citrus fruits, nuts, and organ meats—rather than foods fortified with synthetic folic acid. 1
Natural folates are already in reduced forms closer to 5-MTHF and don't create the same metabolic bottleneck as synthetic folic acid in TT homozygotes. 1
Why This Matters for Your Health
Cardiovascular Risk
Your TT genotype increases risk of hyperhomocysteinemia, which confers a 2–3 fold increased risk of atherosclerotic vascular disease and stroke. 1, 5
Each 5 µmol/L increase in homocysteine raises stroke risk by 59%; conversely, each 3 µmol/L decrease lowers stroke risk by 24%. 1, 5
When hyperhomocysteinemia coexists with Factor V Leiden, the combined effect yields approximately 20-fold greater risk of venous thrombosis. 1
Nutrient Sensitivity
Your TT genotype creates a bottleneck in one-carbon metabolism, making you more vulnerable to relative vitamin deficiencies that wouldn't affect individuals with normal MTHFR function. 1
The MTHFR polymorphism influences B vitamin effects most strongly in TT homozygotes—you are particularly sensitive to the status of multiple B vitamins simultaneously. 3
Common Pitfalls to Avoid
Do not use standard folic acid supplements—they require conversion by your deficient enzyme and are significantly less effective. 1
Do not use cyanocobalamin (the synthetic B12 in most multivitamins)—it is less effective at reducing homocysteine than methylcobalamin or hydroxycobalamin. 1
Do not supplement with folate alone without including riboflavin—riboflavin is the essential cofactor your residual MTHFR activity depends on. 1
Do not assume a standard multivitamin provides adequate doses—TT homozygotes require higher doses of active forms, not the minimal amounts in typical multivitamins. 1
Monitoring Your Response
Measure fasting plasma homocysteine 6–8 weeks after starting supplementation to assess biochemical response. 5
Target homocysteine levels below 10–15 µmol/L; cardiovascular risk begins to rise at 10 µmol/L. 5
The strongest evidence for cardiovascular benefit comes from treatment durations exceeding 3 years with homocysteine reductions greater than 20%. 5